Qureshi Sajid S, Chaukar Devendra A, Talole Sanjay D, D'Cruz Anil K
Department of Head and Neck Services, Tata Memorial Hospital, Parel,Mumbai - 400 012, India.
Indian J Cancer. 2006 Jan-Mar;43(1):26-9. doi: 10.4103/0019-509x.25772.
The optimal treatment of maxillary sinus carcinoma remains to be defined and there is a paucity of Indian studies on the subject.
To present experience of management of squamous cell carcinoma of the maxillary sinus treated with curative intent at a single institution.
Retrospective study of patients with squamous cell carcinoma of the maxillary sinus who presented between 1994 to 1999.
The records of 73 patients with squamous cell carcinoma of the maxillary sinus were analyzed. Sixty-two patients were evaluable. Forty patients (65%) were treated with surgery followed by postoperative radiotherapy, five patients (8%) were treated with radiotherapy alone, five patients (8%) were treated with surgery alone; 12 patients (19%) received chemotherapy.
Statistical analysis was done using Kaplan-Meier method.
The majority of patients presented with locally advanced disease (52, 84%); nodal involvement was observed in five patients (8%). The most common site of recurrence was at the primary site, which was observed in 28 patients (45%) and regional failures occurred in 10 (16%). The 3 and 5-year overall survival was 38% and 35% and the disease free survival was 29% and 26% respectively. The 5-year overall survival after surgery and postoperative radiotherapy was 42%.
The majority of patients present with advanced disease resulting in poor outcomes to conventional treatment modalities. Locoregional tumor progression remains a significant pattern of failure. New approaches such as neoadjuvant or concomitant chemoradiotherapy with aggressive surgery need to be considered and evaluated in prospective studies.
上颌窦癌的最佳治疗方法仍有待确定,并且关于该主题的印度研究较少。
介绍在单一机构对有治愈意向的上颌窦鳞状细胞癌进行治疗的经验。
对1994年至1999年间就诊的上颌窦鳞状细胞癌患者进行回顾性研究。
分析73例上颌窦鳞状细胞癌患者的记录。62例患者可进行评估。40例患者(65%)接受手术治疗,随后进行术后放疗;5例患者(8%)仅接受放疗;5例患者(8%)仅接受手术治疗;12例患者(19%)接受化疗。
采用Kaplan-Meier方法进行统计分析。
大多数患者呈现局部晚期疾病(52例,84%);5例患者(8%)观察到有淋巴结受累。最常见的复发部位是原发部位,28例患者(45%)出现该情况,区域复发10例(16%)。3年和5年总生存率分别为38%和35%,无病生存率分别为29%和26%。手术及术后放疗后的5年总生存率为42%。
大多数患者呈现晚期疾病,导致传统治疗方式效果不佳。局部区域肿瘤进展仍然是显著的失败模式。需要在前瞻性研究中考虑并评估新的方法,如新辅助或同步放化疗联合积极手术。